Microvascular Function in Chronic Kidney Disease
Microvascular Function in Chronic Kidney Disease
批准号:
7364266
负责人:
DAVID G EDWARDS
金额:
$21.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-08-01 至 2011-07-31
关键词:
ArginineAscorbic AcidAtherosclerosisAxonBiodegradationBlood VesselsCardiovascular DiseasesCardiovascular systemChronic Kidney FailureCutaneousDevelopmentDialysis procedureEnd stage renal failureEventFree RadicalsFunctional disorderHeatingHemodialysisInvestigationKidneyKidney DiseasesLaser-Doppler FlowmetryLeadMeasuresMediatingMicrocirculationMicrodialysisMorbidity - disease rateN,N-dimethylarginineNatureNitric OxideNitric Oxide SynthaseOutcomeOxidative StressPatientsPhysical DialysisPlayPopulationProcessProductionPurposeReflex actionRelative (related person)Renal functionResearchRoleSecondary toSiteSkinTherapeuticTherapy EvaluationThinkingVasodilationcardiovascular disorder riskcardiovascular risk factorhuman NOS3 proteinimprovedinhibitor/antagonistinnovationmortalityresponsetherapy designtool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Endothelial dysfunction is recognized as a key process in the development and progression of chronic
kidney disease (CKD). Additionally, endothelial dysfunction is thought to contribute to the increased risk for
CVD in this population. Impaired endothelial function is a primary event in the development of
atherosclerosis and it is now recognized that cardiovascular disease (CVD) is the most important cause of
morbidity and mortality in CKD. An understanding of the mechanisms responsible for endothelial
dysfunction in CKD is important for improving renal and cardiovascular outcomes. Oxidative stress is
elevated in patients with CKD and those on hemodialysis (HD) and has the potential to impair endothelial
function. Thus, endothelial dysfunction secondary to oxidative stress may be a mechanism by which renal
function deteriorates and CVD risk increases in CKD. Additionally, asymmetric dimethylarginine (ADMA),
an endogenous inhibitor of nitric oxide synthase (NOS), is elevated in CKD and can reduce NO production
by competing with L-arginine for NOS. Thus, a relative deficit in L-arginine may result from the competition
between ADMA and L-arginine for endothelial NOS. Investigations into the mechanism(s) of endothelial
dysfunction in CKD have the potential to lead to development of therapeutic measures aimed at maintaining
renal function and reducing cardiovascular risk. Most studies of endothelial function in renal disease have
been performed in end stage renal disease and have focused on the macrocirculation. We propose to
study endothelial function in patients with moderate to severe CKD before they require dialysis.
Additionally, we propose to study the mechanisms of reduced NO bioactivity of the microcirculation by
assessing cutaneous vasodilation in response to local heating by using laser Doppler flowmetry and
intradermal microdialysis. Impaired microvascular function is a systemic process thus the skin provides an
accessible site for the study of the microvasculature. The hyperemic response to local heating of the skin
results in an initial peak that is axon-reflex mediated and a sustained plateau that is dependent on NO and
provides a valuable tool for studying microvascular endothelial function. The aims of this study are 1) To
determine if oxidative stress plays a mechanistic role in reducing nitric oxide-mediated cutaneous
vasodilation in response to local heating in patients with moderate to severe CKD and 2) To determine if a
relative deficit of L-arginine contributes to reduced nitric-oxide mediated cutaneous vasodilation in patients
with moderate to severe CKD. These studies are innovative in that they will generate new information
regarding the mechanisms of impaired NO bioactivity in the microcirculation of CKD patients. Therefore,
the successful completion of this project would be expected to have a potentially important impact by
expanding our understanding of endothelial dysfunction in CKD which may lead to therapies designed to
maintain renal function and reduce cardiovascular risk in this population. Narrative
The purpose of this project is to investigate the mechanisms of vascular dysfunction in chronic kidney
disease in order to better understand the factors that lead to a progression of renal disease and the
development of cardiovascular disease. Understanding these mechanisms may aid in the evaluation of
therapies aimed at improving vascular function in chronic kidney disease.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Center of Biomedical Research Excellence in Cardiovascular Health
-
批准号:9883011
-
项目类别:
-
资助金额:$234.0万
-
财政年份:2016
-
负责人:DAVID G EDWARDS
-
依托单位:
Center of Biomedical Research Excellence in Cardiovascular Health Administrative Core
-
批准号:10640262
-
项目类别:
-
资助金额:$60.93万
-
财政年份:2016
-
负责人:DAVID G EDWARDS
-
依托单位:
Center of Biomedical Research Excellence in Cardiovascular Health Administrative Core
-
批准号:10271698
-
项目类别:
-
资助金额:$44.53万
-
财政年份:2016
-
负责人:DAVID G EDWARDS
-
依托单位:
Center of Biomedical Research Excellence in Cardiovascular Health
-
批准号:10640261
-
项目类别:
-
资助金额:$231.34万
-
财政年份:2016
-
负责人:DAVID G EDWARDS
-
依托单位:
Center of Biomedical Research Excellence in Cardiovascular Health
-
批准号:10271697
-
项目类别:
-
资助金额:$229.67万
-
财政年份:2016
-
负责人:DAVID G EDWARDS
-
依托单位:
Center of Biomedical Research Excellence in Cardiovascular Health
-
批准号:10475082
-
项目类别:
-
资助金额:$234.73万
-
财政年份:2016
-
负责人:DAVID G EDWARDS
-
依托单位:
Center of Biomedical Research Excellence in Cardiovascular Health Administrative Core
-
批准号:10475083
-
项目类别:
-
资助金额:$60.93万
-
财政年份:2016
-
负责人:DAVID G EDWARDS
-
依托单位:
Exercise and Vascular Function in Chronic Kidney Disease
-
批准号:8699826
-
项目类别:
-
资助金额:$39.22万
-
财政年份:2013
-
负责人:DAVID G EDWARDS
-
依托单位:
Exercise and Vascular Function in Chronic Kidney Disease
-
批准号:8437917
-
项目类别:
-
资助金额:$41.24万
-
财政年份:2013
-
负责人:DAVID G EDWARDS
-
依托单位:
Exercise and Vascular Function in Chronic Kidney Disease
-
批准号:8862523
-
项目类别:
-
资助金额:$38.42万
-
财政年份:2013
-
负责人:DAVID G EDWARDS
-
依托单位:
Vascular effects of dietary salt in humans with salt-resistant BP
-
批准号:8186146
-
项目类别:
-
资助金额:$39.74万
-
财政年份:2011
-
负责人:DAVID G EDWARDS
-
依托单位:
Vascular effects of dietary salt in humans with salt-resistant BP
-
批准号:8329607
-
项目类别:
-
资助金额:$38.42万
-
财政年份:2011
-
负责人:DAVID G EDWARDS
-
依托单位:
Vascular effects of dietary salt in humans with salt-resistant BP
-
批准号:8698453
-
项目类别:
-
资助金额:$37.06万
-
财政年份:2011
-
负责人:DAVID G EDWARDS
-
依托单位:
VASCULAR EFFECTS OF DIETARY SALT IN HUMANS WITH SALT-RESISTANT BP
-
批准号:9981485
-
项目类别:
-
资助金额:$59.27万
-
财政年份:2011
-
负责人:DAVID G EDWARDS
-
依托单位:
Vascular effects of dietary salt in humans with salt-resistant BP
-
批准号:8507269
-
项目类别:
-
资助金额:$36.55万
-
财政年份:2011
-
负责人:DAVID G EDWARDS
-
依托单位:
VASCULAR EFFECTS OF DIETARY SALT IN HUMANS WITH SALT-RESISTANT BP
-
批准号:10214661
-
项目类别:
-
资助金额:$59.27万
-
财政年份:2011
-
负责人:DAVID G EDWARDS
-
依托单位:
Oxidative Stress and Vascular Function in Chronic Kidney Disease
-
批准号:7313224
-
项目类别:
-
资助金额:$23.24万
-
财政年份:2007
-
负责人:DAVID G EDWARDS
-
依托单位:
Oxidative Stress and Vascular Function in Chronic Kidney Disease
-
批准号:7476485
-
项目类别:
-
资助金额:$17.92万
-
财政年份:2007
-
负责人:DAVID G EDWARDS
-
依托单位:
COBRE in CV Health Research Core
-
批准号:9883020
-
项目类别:
-
资助金额:$24.58万
-
财政年份:--
-
负责人:DAVID G EDWARDS
-
依托单位:
COBRE in CV Health Research Core
-
批准号:8813033
-
项目类别:
-
资助金额:$39.1万
-
财政年份:--
-
负责人:DAVID G EDWARDS
-
依托单位:
海外基金